Home › Gastrointestinal Stromal Tumors › Michigan › Ann Arbor
Gastrointestinal Stromal Tumors clinical trials in Ann Arbor, MI
4 studies for Gastrointestinal Stromal Tumors are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy
RecruitingPhase 3
- GSK Investigational Site, Ann Arbor
KQB198 in Combination With Imatinib in Participants With Advanced/Metastatic GIST in 1st Line Setting (SynerGIST-1st Line)
RecruitingPhase 2
- University of Michigan Hospitals, Ann Arbor
A Study of Ziftomenib in Combination With Imatinib in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)
RecruitingPhase 1
- University of Michigan, Ann Arbor
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
RecruitingPhase 1
- University of Michigan Hospitals, Ann Arbor
Gastrointestinal Stromal Tumors trials in other cities
- Miami, FL8 studies
- Boston, MA7 studies
- New York City, NY7 studies
- Houston, TX6 studies
- Philadelphia, PA6 studies
- Nashville, TN5 studies
- San Diego, CA5 studies
- Portland, OR5 studies
- Omaha, NE5 studies
- Dallas, TX4 studies
- Durham, NC4 studies
- Los Angeles, CA4 studies
Other studies in Ann Arbor
- Breast Cancer27 studies
- Prostate Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Cancer (all types)25 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Stroke12 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.